CD1D and inflammatory bowel disease: Remarkably, CD1d expression has been reported to be reduced in the intestine of patients with inflammatory bowel diseases (IBD) (Perera et al., 2007), supporting the idea that reverse signalling through CD1d could be a key regulator of the host response to environmental stimuli and potentially contribute to the control of intestinal inflammation.